Superior vena cava syndrome epidemiology and demographics

Superior Vena Cava Syndrome Microchapters
Home
Patient Information
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Superior Vena Cava Syndrome from Other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Staging
History and Symptoms
Physical Examination
Laboratory Findings
Chest X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Radiation Therapy
Surgery
Primary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Superior vena cava syndrome epidemiology and demographics On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Superior vena cava syndrome epidemiology and demographics All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Superior vena cava syndrome epidemiology and demographics
CDC on Superior vena cava syndrome epidemiology and demographics
Superior vena cava syndrome epidemiology and demographics in the news
Blogs on Superior vena cava syndrome epidemiology and demographics
Directions to Hospitals Treating Superior vena cava syndrome
Risk calculators and risk factors for Superior vena cava syndrome epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Maria Fernanda Villarreal, M.D. [2]

Overview

Superior vena cava syndrome is a common oncologic emergency. The incidence rate in the United States is approximately 15,000 individuals each year. The incidence of superior vena cava syndrome increases with age; the median age of diagnosis is between 40-60 years. Males are more commonly affected with superior vena cava syndrome than females.

Epidemiology and Demographics

Prevalence

• The prevalence of superior vena cava syndrome remains unknown.

Incidence

• In the United States, the incidence of superior vena cava syndrome is 15,000 individuals each year.

Gender

• Males are more commonly affected with superior vena cava syndrome than females due to the higher incidence of lung cancer among males.

Race

• The prevalence of SVCS does not vary by race. However, depending on the type of cancer a racial predilection may be possible.